Equities
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (EUR)18.68
  • Today's Change0.49 / 2.69%
  • Shares traded866.92k
  • 1 Year change-16.23%
  • Beta0.5845
Data delayed at least 15 minutes, as of Nov 08 2024 16:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 16-Nov-23
  • 15-Aug-24
  • 19-Sep-24
  • 17-Oct-24
  • 07-Nov-24
Select bar for recommendation details.
Recommendations07-Nov-24
Buy5
Outperform10
Hold6
Sell1
Strong Sell1

Share price forecast in EUR

The 22 analysts offering 12 month price targets for Jeronimo Martins SGPS SA have a median target of 21.10, with a high estimate of 26.00 and a low estimate of 15.00. The median estimate represents a 12.96% increase from the last price of 18.68.
High39.2%26.00
Med13.0%21.10
Low-19.7%15.00

Dividends in EUR

In 2023, Jeronimo Martins SGPS SA reported a dividend of 0.47 EUR, which represents a 19.09% increase over last year. The 17 analysts covering the company expect dividends of 0.61 EUR for the upcoming fiscal year, an increase of 29.13%.
Div growth (TTM)19.09%
More ▼

Earnings history & estimates in EUR

On Oct 30, 2024, Jeronimo Martins SGPS SA reported 3rd quarter 2024 earnings of 0.31 per share. This result exceeded the 0.25 consensus of the 5 analysts covering the company and under-performed last year's 3rd quarter results by 6.06%.
The next earnings announcement is expected on Mar 17, 2025.
Average growth rate+0.28%
Jeronimo Martins SGPS SA reported annual 2023 earnings of 1.29 per share on Mar 06, 2024.
Average growth rate+23.23%
More ▼

Revenue history & estimates in EUR

Jeronimo Martins, SGPS, S.A. had 3rd quarter 2024 revenues of 8.47bn. This bettered the 8.47bn consensus of the 10 analysts covering the company. This was 24.44% above the prior year's 3rd quarter results.
Average growth rate+1.64%
Jeronimo Martins, SGPS, S.A. had revenues for the full year 2023 of 30.61bn. This was 20.58% above the prior year's results.
Average growth rate+13.47%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.